<bold> COMBINATION OF TUMOR TREATING FIELDS </bold>(TTFIELDS) WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PATIENTS - A BI-CENTRIC ANALYSIS

被引：0
|
作者：
Lazaridis, Lazaros [1 ]
Schaefer, Niklas [2 ]
Schmidt, Teresa [3 ]
Weller, Johannes [2 ]
Tzaridis, Theophilos-Dimitrios [2 ]
Scheffler, Bjoern [4 ]
Pierscianek, Daniela [5 ]
Kleinschnitz, Christoph [6 ]
Stuschke, Martin [7 ]
Sure, Ulrich [5 ]
Herrlinger, Ulrich [2 ]
Kebir, Sied [1 ]
Glas, Martin [3 ]
机构：
[1] Univ Hosp Essen, Div Clin Neurooncol, Dept Neurol, Essen, Germany
[2] Univ Bonn, Div Clin Neurooncol, Dept Neurol, Med Ctr, Bonn, Germany
[3] Univ Duisburg Essen, Univ Hosp Essen, Div Clin Neurooncol, Dept Neurol, Essen, Germany
[4] Partner Site Univ Hosp Essen, German Canc Consortium DKTK, West German Canc Ctr WTZ, DKFZ,Div Translat Neurooncol, Essen, Germany
[5] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurosurg, Essen, Germany
[6] Univ Duisburg Essen, Univ Hosp Essen, Dept Neurol, Essen, Germany
[7] Univ Duisburg Essen, Univ Hosp Essen, Dept Radiotherapy, Essen, Germany
来源：
NEURO-ONCOLOGY | 2019年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
RARE-39
引用
收藏
页码：229 / 230
页数：2
相关论文
共 50 条
  • [1] TUMOR TREATING FIELDS (TTFIELDS) COMBINED WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM) PATIENTS - A BI-CENTRIC ANALYSIS
    Lazaridis, L.
    Schaefer, N.
    Schmidt, T.
    Stoppek, A.
    Weller, J.
    Tzaridis, T.
    Scheffler, B.
    Pierscianek, D.
    Kleinschnitz, C.
    Stuschke, M.
    Sure, U.
    Herrlinger, U.
    Kebir, S.
    Glas, M.
    NEURO-ONCOLOGY, 2019, 21 : 81 - 81
  • [2] TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Lazaridis, Lazaros
    Schaefer, Niklas
    Kebir, Sied
    Weller, Johannes
    Tzaridis, Theophilos-Dimitrios
    Scheffler, Bjoern
    Pierscianek, Daniela
    Kleinschnitz, Christoph
    Stuschke, Martin
    Sure, Ulrich
    Herrlinger, Ulrich
    Glas, Martin
    NEURO-ONCOLOGY, 2018, 20 : 119 - 120
  • [3] Combination of Tumor Treating Fields (TTFields) with lomustine (CCNU) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM)
    Lazaridis, L.
    Kebir, S.
    Weller, J.
    Tzaridis, T. -D
    Scheffler, B.
    Pierscianek, D.
    Kleinschnitz, C.
    Stuschke, M.
    Sure, U.
    Herrlinger, U.
    Schaefer, N.
    Glas, M.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S109 - S109
  • [4] TUMOR TREATING FIELDS (TTFIELDS) IN COMBINATION WITH LOMUSTINE (CCNU) AND TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Lazaridis, L.
    Schaefer, N.
    Kebir, S.
    Weller, J.
    Tzaridis, T.
    Schaeffler, B.
    Pierscianek, D.
    Kleinschnitz, C.
    Stuschke, M.
    Sure, U.
    Herrlinger, U.
    Glas, M.
    NEURO-ONCOLOGY, 2018, 20 : 230 - 230
  • [5] Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
    Lazaros Lazaridis
    Niklas Schäfer
    Sarah Teuber-Hanselmann
    Tobias Blau
    Teresa Schmidt
    Christoph Oster
    Johannes Weller
    Theophilos Tzaridis
    Daniela Pierscianek
    Kathy Keyvani
    Christoph Kleinschnitz
    Martin Stuschke
    Björn Scheffler
    Cornelius Deuschl
    Ulrich Sure
    Ulrich Herrlinger
    Sied Kebir
    Martin Glas
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 787 - 792
  • [6] Tumour Treating Fields (TTFields) in combination with lomustine and temozolomide in patients with newly diagnosed glioblastoma
    Lazaridis, Lazaros
    Schaefer, Niklas
    Teuber-Hanselmann, Sarah
    Blau, Tobias
    Schmidt, Teresa
    Oster, Christoph
    Weller, Johannes
    Tzaridis, Theophilos
    Pierscianek, Daniela
    Keyvani, Kathy
    Kleinschnitz, Christoph
    Stuschke, Martin
    Scheffler, Bjoern
    Deuschl, Cornelius
    Sure, Ulrich
    Herrlinger, Ulrich
    Kebir, Sied
    Glas, Martin
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (03) : 787 - 792
  • [7] PHASE III TRIAL OF TUMOR TREATING FIELDS (TTFIELDS) TOGETHER WITH TEMOZOLOMIDE (TMZ) COMPARED TO TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
    Farber, Ori
    Weinberg, Uri
    Palti, Yoram
    NEURO-ONCOLOGY, 2013, 15 : 76 - 77
  • [8] COMBINATION OF TUMOR TREATING FIELDS (TTFIELDS) AND RADIOCHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
    Avgoustidou, M.
    Mahlknecht, U.
    NEURO-ONCOLOGY, 2018, 20 : 235 - 235
  • [9] Tumor Treating Fields (TTFields) in combination with radiochemotherapy in patients with newly diagnosed glioblastoma
    Avgoustidou, M.
    Mahlknecht, U.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 : S59 - S59
  • [10] APPLICATION OF RTOG-RPA SCORES IN A PHASE 3 TRIAL OF TUMOR TREATING FIELDS WITH TEMOZOLOMIDE (TTFIELDS/TMZ) VERSUS TEMOZOLOMIDE (TMZ) ALONE IN NEWLY DIAGNOSED GLIOBLASTOMA
    Choe, Kevin
    Idbaih, Ahmed
    Taillibert, Sophie
    Escuder, Jordi Bruna
    Sroubek, Jan
    Kanner, Andrew
    NEURO-ONCOLOGY, 2017, 19 : 8 - 9
12345